Stay tuned and follow the latest
developments and news in Molecular Oncology.
Genekor supports the efforts of the Hellenic National Anti-Epilepsy Association (E.E.E.E.E.) and the Panhellenic Scientific Association against Epilepsy (P.E.S.E.) for the information and awareness of epilepsy. We believe in equal […]
Read More
Genekor, with a focus on the prevention and early diagnosis of genetic diseases, offers free genetic counseling to all examinees who wish, before, during and/or after genetic testing for hereditary […]
Read More
This year, World Cancer Day coincides with the date of the 8th Annual Conference of the Hellenic Cancer Federation (ELLOK): ‘Man at the Centre: Co-Creating the Context”. In this context, […]
Read More
Approximately 8,000 women with early breast cancer in Greece were able to avoid chemotherapy thanks to Oncotype DX®’s decision guidance This year marks 15 years since the introduction of the […]
Read More
The study by the Genekor Scientific Team, titled “RediScore: Prospective Validation of a Pipeline for Homologous Recombination Deficiency Analysis,” was published in Oncology Letters The study by the Genekor Scientific […]
Read More
prime DXThe prime DX assay provides a detailed blueprint of tumor biology, which is used by the physician to design the most effective individualized treatment plan for the patient.It includes […]
Read More
W4O Hellas & ARTE in collaboration with Genekor Medical S.A give women the opportunity to do a Free Genetic Test for hereditary predisposition to breast-ovarian cancer. The company Genekor actively […]
Read More
3 Scientific Papers have been accepted by ASCO, to be presented at this year’s conference in June. Genekor scientists, Hospitals and Doctors participated in the investigations, presenting substantial findings concerning […]
Read More
. Nikos Tsoulos MSc, MBA, PhDc, Biochemist, CEO, GeneKor Medical SA gave a speech entitled “The present and future of biomarkers in the Greek health system” he stated that today, […]
Read More